The Zacks Analyst Blog Meta, Pfizer, Salesforce and Smith-MidlandZacks Investment Research • 05/14/26
European Commission Approves Pfizer's HYMPAVZI for the Treatment of Adults and Adolescents with Hemophilia A or B With InhibitorsBusiness Wire • 05/13/26
Arvinas and Pfizer Enter into a Transaction with Rigel Pharmaceuticals for the Exclusive Global Rights of VEPPANU (vepdegestrant)GlobeNewsWire • 05/12/26
Moderna Stock Is Up 6% Today: Is It Outperforming Other Vaccine Stocks Like Pfizer and Novavax?24/7 Wall Street • 05/11/26
Could Buying This Beaten-Down Healthcare Stock Make You Rich If It Recovers?The Motley Fool • 05/09/26
Obvious Dividend Traps: 4 We Exited And 1 We Wouldn't Touch With A 10-Foot PoleSeeking Alpha • 05/07/26
6 Pharma Dividend Stocks Yielding Up to 6.44% — and They've Survived Every Market Crash24/7 Wall Street • 05/06/26
Pfizer Beats on Q1 Earnings, New & Acquired Drugs Drive Sales GrowthZacks Investment Research • 05/05/26